MedTrace Logo

Novel Organic Kale Products for Prevention of Obesity/Type 2 Diabetes

NCT04298970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-12-04

No results posted yet for this study

Summary

Investigating the health beneficial effects of freeze-dried Brassica oleracea var. acephala with a high content of fibers, protein, vitamin, minerals, and secondary metabolites on patients with type 2 diabetes.

Conditions

  • Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Intervention

Freeze-dried Brassica oleracea var. acephala

DIETARY_SUPPLEMENT

Placebo

Placebo product

Sponsors & Collaborators

  • Future Food Innovation

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-03
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04298970 on ClinicalTrials.gov